Article citationsMore >>

Antunes, L.C., Elkfury, J.L., Jornada, M.N., Foletto, K.C., Bertoluci, M.C. “Validation of HOMA-IR in a model of insulin-resistance induced by a high-fat diet in Wistar rats”. Arch Endocrinol Metab. 60, 2, 138-142, 2016.

has been cited by the following article:

Article

Anthocyanin Extract of Purple Corn Improves Hyperglycemia and Insulin Resistance of Rats Fed High Fat and Fructose Diet via GLP1 and GLP1R Mechanism

1Department of Food and Fashion Engineering Education, Faculty of Engineering, Yogyakarta State University, Yogyakarta, Indonesia 55281

2Doctoral Program of Food Science, Department of Food and Agricultural Product Technology, Gadjah Mada University, Yogyakarta, Indonesia 55281

3Department of Biochemistry, Faculty of Medicine, Public Health and Nursing, Gadjah Mada University, Yogyakarta, Indonesia 55281

4Department of Food and Agricultural Product Technology, Faculty of Agricultural Technology, Gadjah Mada University, Yogyakarta, Indonesia 55281


Journal of Food and Nutrition Research. 2019, Vol. 7 No. 4, 303-310
DOI: 10.12691/jfnr-7-4-7
Copyright © 2019 Science and Education Publishing

Cite this paper:
Ichda Chayati, Sunarti, Yustinus Marsono, Mary Astuti. Anthocyanin Extract of Purple Corn Improves Hyperglycemia and Insulin Resistance of Rats Fed High Fat and Fructose Diet via GLP1 and GLP1R Mechanism. Journal of Food and Nutrition Research. 2019; 7(4):303-310. doi: 10.12691/jfnr-7-4-7.

Correspondence to: Ichda  Chayati, Department of Food and Fashion Engineering Education, Faculty of Engineering, Yogyakarta State University, Yogyakarta, Indonesia 55281. Email: ichda_chayati@uny.ac.id

Abstract

Hyperglycemia and insulin resistance are caused by high fat, fructose, or fat and fructose diet. The aim of this study was to investigate the effect of anthocyanin extract of purple corn (AEPC) on insulin resistance of rats fed high fat and fructose diet (HFFD). Insulin resistance was induced by feeding HFFD for 4 weeks and Wistar male rats were orally supplemented with the following treatments for the next six weeks: pioglitazone 1.35 mg kg-1 body weight (bw) as a positive control group (PC), AEPC 6 mg kg-1 bw (LA), AEPC 12.5 mg kg-1 bw (MA), and AEPC 25 mg kg-1 bw (HA), or no treatment as a negative control group (NC). A normal control group was fed a normal diet (NLC) for along 10 weeks. Insulin resistance was indicated by Homeostasis Model Assessments for Insulin Resistance (HOMA-IR) scores. The results showed that HFFD feeding increased HOMA-IR score and blood glucose levels, and decreased levels of plasma glucagon-like peptide 1 (GLP1) and pancreatic glucagon-like peptide 1 receptor (GLP1R). Administration of AEPC reduced HOMA-IR scores and blood glucose levels, increased HOMA-β and HOMA-IS scores, plasma GLP1 and pancreatic GLP1R levels, and improved pancreatic morphology. Our finding suggests that AEPC 12.5 mg kg-1 bw gave the best conditions to improve insulin resistance as well as standard drug administration pioglitazone 1.35 mg kg-1 bw via GLP1 and GLP1R mechanism.

Keywords